Study of Multiple Myeloma Occurrence in Patients With 5%-10% Bone Marrow Plasma Cells: A Case Series Regarding Revised IMWG Diagnostic Criteria

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 192

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MCIJO-2-3_004

تاریخ نمایه سازی: 28 بهمن 1399

Abstract:

Introduction: Utilizing lower limit of bone marrow plasma cells (BMPCs) is the main existing criterion for diagnosis of multiple myeloma (MM). According to the revised international myeloma working group (IMWG) diagnostic criteria, the value of 10% is agreed among experts as the cutoff level for diagnosis. Symptomatic patients with BMPC above this value are identified as definite cases of MM. However, there are MM patients who have BMPC of less than 10%. Considering abovementioned cutoff could delay the diagnosis which in turn results in adverse effects in patients’ clinical course. Case presentation: This study represented data of consecutive patients with 5% to 10% BMPC at our center from 2004 to 2013. MM existed among patients, as expected. This series provides a quantitative approximation of MM prevalence in these cases. Conclusion: The reported patients’ status demonstrates the limitations of the abovementioned cutoff criterion in myeloma diagnosis, and emphasizes the importance of employing further diagnostic procedures in patients with marginal amounts of BMPC and high clinical suspicion. It has been shown that supplementary examination is especially required for two subgroups of patients with certain clinical and laboratory characteristics. The detail of the cases and results are thoroughly explained in the paper. 

Authors

Hasan Jalaeikhoo

AJA Cancer Epidemiology Research and Treatment Center (AJA- CERTC), AJA University of Medical Sciences, Tehran, Iran.

Mohammad Zokaasadi

AJA Cancer Epidemiology Research and Treatment Center (AJA- CERTC), AJA University of Medical Sciences, Tehran, Iran.

Mohsen Rajaeinejad

AJA Cancer Epidemiology Research and Treatment Center (AJA- CERTC), AJA University of Medical Sciences, Tehran, Iran.

Manoutchehr Keyhani

Hematology and Oncology Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Address: Keshavarz Blvd., Imam Khomeini Hospital Complex, Vali-Asr hospital, Tehran, Iran.

Morteza Sharifzadeh

AJA Cancer Epidemiology Research and Treatment Center (AJA- CERTC), AJA University of Medical Sciences, Tehran, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Bergin K, McQuilten Z, Moore E, Wood E, Spencer A. ...
  • 2. Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. ...
  • 3. Kyle RA. Multiple Myeloma. Diagnostic challenges and standard therapy. Semin ...
  • 4. Moreau P, San Miguel J, Sonneveld P, Mateos MV, Zamagni ...
  • 5. Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, ...
  • 6. Rajkumar SV, Fonseca R, San Miguel JF. Diagnosis and Staging ...
  • 7. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Mer- lini ...
  • 8. International Myeloma Working G. Criteria for the classi-fication of monoclonal ...
  • 9. Johnsen HE, Bogsted M, Klausen TW, Gimsing P, Schmitz A, ...
  • 10. Kariyawasan CC, Hughes DA, Jayatillake MM, Mehta AB. Multiple myeloma: ...
  • 11. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, ...
  • multiple myeloma. Mayo Clin Proc. 2003;78(1):21-33. DOI: 10.4065/78.1.21 PMID: 12528874. ...
  • 12. Walker RC, Brown TL, Jones-Jackson LB, De Blanche L, ...
  • نمایش کامل مراجع